Ferriprox Related Clinical Trials
Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox� in Patients With Sickle Cell Disease [Completed]
Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers [Active, not recruiting]
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects [Completed]
A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN) [Active, not recruiting]
A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers [Completed]
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias [Recruiting]
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers [Completed]
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias [Enrolling by invitation]
Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers [Completed]
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment [Completed]
Pilot Study of the Pharmacokinetic Profile of a Single Dose of Deferiprone Sustained-Release Formulation in Healthy Volunteers [Completed]
Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects [Completed]
Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease [Completed]
A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia [Completed]
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration [Enrolling by invitation]
Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects [Recruiting]
Active Drug Surveillance Program of Ferriprox Use [Completed]
A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease [Recruiting]
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease [Approved for marketing]
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients [Completed]
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients [Completed]
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients [Not yet recruiting]
Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent [Not yet recruiting]
Pharmacokinetic Study of Deferiprone in Paediatric Patients [Completed]
A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia [Completed]
Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients [Active, not recruiting]
Efficacy Study in Removing Excess Iron From the Heart [Completed]
Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) [Active, not recruiting]
Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis [Active, not recruiting]
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients [Not yet recruiting]
Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients [Completed]
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major [Completed]
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml) [Not yet recruiting]
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP [Completed]
Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients [Completed]
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases [Terminated]
Amlodipine for Myocardial Iron in Thalassemia [Active, not recruiting]
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) [Completed]
Role of Vitamin C to Augment Iron Chelation With DFP or DFX [Not yet recruiting]
A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity [Completed]
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis [Completed]
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis [Completed]
Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC [Not yet recruiting]
Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma [Completed]
Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients [Active, not recruiting]
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer [Completed]
|